In the latest close session, Johnson & Johnson (JNJ) was down 1.2% at $155.22. The stock fell short of the S&P 500, which registered a gain of 0.94% for the day. Meanwhile, the Dow experienced a rise ...

According to Benzinga Pro, Johnson & Johnson's peer group average for short interest as a percentage of float is 4.04%, which ...

Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

Johnson & Johnson is a diversified healthcare giant. J&J has increased its dividend for 63 consecutive years. One high-yield ...

The stock price of Johnson & Johnson has outperformed the broader indices over the last month or so. While the S&P500 index has seen a rise of 1% over the last one month, JNJ stock is up around 5%.

In this note, we discuss Johnson & Johnson’s stock performance, key takeaways from its recent results, and valuation. Johnson & Johnson’s Q3 Performance Was Better Than Estimates Johnson ...

Johnson & Johnson (NYSE: JNJ) is one of the world's largest and most prominent healthcare leaders. If investing in a company came down to size, the stock would be a no-brainer buy. However ...

Here's a step-by-step on how to buy shares of Johnson & Johnson and some factors to consider before investing in the healthcare stock. Fidelity makes it easy to buy stocks. Its website offers a ...

Is now a good time to buy this top healthcare stock? There's no doubt that Johnson & Johnson has a strong, diverse business. But it's hard for investors to properly assess the stock and its ...